What's new

Date Content
29/06/2018 News and press releases: First two CAR-T cell medicines recommended for approval in the European Union
29/06/2018 Summary of opinion: RoActemra, tocilizumab, 28/06/2018, Positive
29/06/2018 News and press releases: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 25-28 June 2018
29/06/2018 Summary of opinion: CHMP post-authorisation summary of positive opinion for Inovelon
29/06/2018 News and press releases: Hydroxyethyl starch solutions: CMDh introduces new measures to protect patients
29/06/2018 Regulatory and procedural guideline: Draft qualification opinion on Cellular therapy module of the European Society for Blood & Marrow Transplantation (EBMT) Registry
29/06/2018 Periodic safety update single assessment: Carvedilol / ivabradine: List of nationally authorised medicinal products - PSUSA/00010586/201711
29/06/2018 Orphan designation: 3,4-diaminopyridine phosphate for the: Treatment of Lambert-Eaton myasthenic syndrome, 19/12/2002, Positive
29/06/2018 Orphan designation: Larotrectinib for the: Treatment of salivary gland cancer, 21/03/2018, Positive
29/06/2018 Orphan designation: (S)-N-(5-((R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide hydrogen sulfate (larotrectinib) for the: Treatment of soft tissue sarcoma, 11/01/2016, Positive